Nordic Pharma SAS
16
1
2
10
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
6.3%
1 terminated/withdrawn out of 16 trials
90.9%
+4.4% vs industry average
19%
3 trials in Phase 3/4
0%
0 of 10 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (16)
Prevention of Intra-uterine Adhesions Following Laparoscopic and Laparotomic Myomectomy
Role: collaborator
HYALOBARRIER® GEL ENDO Versus no HYALOBARRIER® GEL ENDO Following Operative Hysteroscopy for Improving Reproductive Outcome in Women With Intrauterine Pathology Wishing to Become Pregnant
Role: collaborator
Therapeutic Strategy Associated With bDMARDs or tsDMARDs in Rheumatoid Arthritis and Psoriatic Arthritis
Role: lead
Feasibility Study of Adjuvant Treatment With S-1 in Patients After R0-Resection of Adenocarcinoma of the Stomach and Esophagogastric Junction
Role: collaborator
Trial of S-1 Maintenance Therapy in Metastatic Esophagogastric Cancer
Role: collaborator
Rheumatoid Arthritis Response to Methotrexate
Role: collaborator
Prevention of Adhesions During Celioscopy for Endometriosis. Impact of the Use of Anti-adhesion Treatment on Clinical Signs and Fertility at One Year
Role: lead
Treatment Adherence to Injectable Methotrexate in Rheumatoid Arthritis
Role: lead
S-1 Versus Capecitabine in the First Line Treatment of MCC Patients.
Role: collaborator
Comparison of Compliance and Evolution of Functional Capacity of Patients With Rheumatoid Arthritis Treated by Methotrexate Either by Auto-injector or by Conventional Sub-cutaneous Syringe
Role: lead
Spinal Versus General Anesthesia for Ambulatory Anesthesia
Role: lead
Efficacy of Mifepristone - Prostaglandin Analogue Combination in Medical Termination of Pregnancy Beyond 7 Weeks of Amenorrhea
Role: lead
Therapeutic Strategy in Patients Treated With Methotrexate for Rheumatoid Arthritis
Role: lead
Clinical Study Comparing the New Immunosuppressive Drug Gusperimus With the Conventional Treatment in Wegener's Granulomatosis
Role: lead
Impact of Chloroprocaine (CLOROTEKAL®) on Eligibility for Discharge From Hospital After Outpatient Surgery
Role: lead
Feasibility of a Self-performed Urinary Test for the Follow-up on Medical Abortion
Role: lead
All 16 trials loaded